APA (7th ed.) Citation

JM, S., B, C., PA, M., PG, M., GC, R., Schildkraut, J. M., . . . Rodriguez, G. C. (2002). Impact of progestin and estrogen potency in oral contraceptives on ovarian cancer risk. JNCI: Journal of the National Cancer Institute, 94(1), 32. https://doi.org/10.1093/jnci/94.1.32

Chicago Style (17th ed.) Citation

JM, Schildkraut, et al. "Impact of Progestin and Estrogen Potency in Oral Contraceptives on Ovarian Cancer Risk." JNCI: Journal of the National Cancer Institute 94, no. 1 (2002): 32. https://doi.org/10.1093/jnci/94.1.32.

MLA (9th ed.) Citation

JM, Schildkraut, et al. "Impact of Progestin and Estrogen Potency in Oral Contraceptives on Ovarian Cancer Risk." JNCI: Journal of the National Cancer Institute, vol. 94, no. 1, 2002, p. 32, https://doi.org/10.1093/jnci/94.1.32.